Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Carrefour: Q3 2015/rather impressive set of figures ahead but some factors to watch (China notably)

BUY-Top Picks, Fair Value EUR31 (+10%)

Published last October Thursday 8, 2015

UCB: Positive for Vimpat's lifecycle management in EU

NEUTRAL vs. NEUTRAL, Fair Value EUR72 vs. EUR71 (+6%)

Published last October Thursday 8, 2015

SABMiller: Offer at GBP42.15

BUY-Top Picks, Fair Value  4215p vs. 5000p (+16%)

Published last October Wednesday 7, 2015

Casino Guichard: Q3 2015 preview

BUY, Fair Value EUR69 (+28%)

Published last October Wednesday 7, 2015

Innate Pharma: AZN should come back… and it may be better than expected

BUY, Fair Value EUR19 (+40%)

Published last October Wednesday 7, 2015

Innate Pharma is added to the list, becoming the fourth healthcare stock in the list for 4Q

Healthcare: Sector View

Published last October Wednesday 7, 2015

Roche ECTRIMS 2015: how big can ocrelizumab be?

BUY, Fair Value CHF327 (+26%)

Published last October Wednesday 7, 2015

SABMiller: Trading Statement

BUY, Fair Value  5000p (+33%)

Published last October Tuesday 6, 2015

Grandvision: Acquisition of For Eyes chain – Welcome to the US!

BUY, Fair Value EUR27,5 (+19%)

Published last October Tuesday 6, 2015

Capgemini: Igate's CEO Ashok Vemuri to leave Capgemini, FY15 guidance reiterated

(BUY, Fair Value EUR96 (+19%)

Published last October Tuesday 6, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities